Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Peter Gale

Showing results (331-340 of 373) with videos related to

Pageof 38
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2015
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning RegimenAlvaro Urbano-Ispizua, Steven Z Pavletic, Mary E Flowers, et al.
The Lancet. Child & Adolescent Health|September 1, 2024
Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort studyJustine Kahn, Ruta Brazauskas, Stephanie Bo-Subait, et al.
Blood Advances|October 25, 2019
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemiaNelli Bejanyan, Soyoung Kim, Kyle M Hebert, et al.
Blood Advances|November 7, 2018
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemiaSaurabh Chhabra, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving ChemotherapyYun Wang, Yan-Yu Cai, Tobias Herold, et al.
Haematologica|April 21, 2022
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysisMatthew Mei, Raju Pillai, Soyoung Kim, et al.
Bone Marrow Transplantation|December 12, 2018
Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Igor Petriček, Linda Burns, et al.
Blood Advances|October 2, 2020
Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDSVikas Gupta, Soyoung Kim, Zhen-Huan Hu, et al.
Bone Marrow Transplantation|February 28, 2019
Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Igor Petriček, Linda Burns, et al.
Cancer|June 18, 2016
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysisAbhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn, et al.
Pageof 38

Showing results (331-340 of 373) with videos related to

Sort By:
Pageof 38
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2015
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning RegimenAlvaro Urbano-Ispizua, Steven Z Pavletic, Mary E Flowers, et al.
The Lancet. Child & Adolescent Health|September 1, 2024
Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort studyJustine Kahn, Ruta Brazauskas, Stephanie Bo-Subait, et al.
Blood Advances|October 25, 2019
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemiaNelli Bejanyan, Soyoung Kim, Kyle M Hebert, et al.
Blood Advances|November 7, 2018
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemiaSaurabh Chhabra, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving ChemotherapyYun Wang, Yan-Yu Cai, Tobias Herold, et al.
Haematologica|April 21, 2022
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysisMatthew Mei, Raju Pillai, Soyoung Kim, et al.
Bone Marrow Transplantation|December 12, 2018
Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Igor Petriček, Linda Burns, et al.
Blood Advances|October 2, 2020
Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDSVikas Gupta, Soyoung Kim, Zhen-Huan Hu, et al.
Bone Marrow Transplantation|February 28, 2019
Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Igor Petriček, Linda Burns, et al.
Cancer|June 18, 2016
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysisAbhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn, et al.
Pageof 38